Camphene Mitigates Cyclophosphamide‐Induced Oxidative Stress, Neuroinflammation, and Cognitive Dysfunction via Nrf2, NF‐κB, and Astrocytic GFAP Modulation in Wistar Albino Rats
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Mohd Almas Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India. Hauptthemen laut MEDLINE: Cyclophosphamide, Oxidative Stress, NF-kappa B, NF-E2-Related Factor 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Cyclophosphamide (CP) is a potent chemotherapeutic medication for various cancer types. Chemotherapy‐associated neurotoxicity is a significant adverse effect seen in cancer patients undergoing treatment with cyclophosphamide. The root cause of this toxicity is the production of reactive oxygen species (ROS). Camphene (CAMP) is a natural substance that has demonstrated its effectiveness as a potent antioxidant and anti‐inflammatory molecule. Hence, we have selected Camphene to evaluate its potential role in mitigating CP‐induced neurotoxicity in rats. CAMP was administered orally at 50, 100, and 200 mg/kg doses from Day 1 to Day 21. On Day 7, the rats were administered with CP at 200 mg/kg via intraperitoneal injection. Neurobehavioral assessments including elevated plus maze test (EPM), forced swim test (FST), grip strength test (GST), and sucrose preference test (SPT) were performed. On Day 21, the rats were euthanized, and their brains were extracted for examining histopathological, Immunohistochemical, Oxidative stress and Anti‐inflammatory parameters. Nuclear Factor kappa B (NF‐κB), Nuclear Factor Erythroid 2–related Factor 2 (Nrf2), Glial Fibrillary Acidic Protein (GFAP), Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Reductase (GR), Thiobarbituric Acid Reactive Substances (TBARS), Interleukin‐6 (IL‐6), Interleukin‐1β (IL‐1β), Interleukin‐10 (IL‐10), and Tumour Necrosis Factor‐alpha (TNF‐α) were assessed. Camphene at 100 and 200 mg/kg exhibited neuroprotective effects and prevented neurological disorders induced by cyclophosphamide (CP) at 200 mg/kg by reversing oxidative stress, inflammation, and neurobehavioral changes. Camphene, thus, exhibited dose‐dependent neuroprotection by increasing antioxidant level, decreasing neuroinflammation, and enhancing behavioural outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India.
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
- Department of Biotech, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi, India.
ORCID-Profile: Mohd Almas Khan, Mohammad Mumtaz Alam, Syed Ehtaishamul Haque
Zitieren
APA
Khan, M. A., Alam, M. M., Ali, S. M., & Haque, S. E. (2025). Camphene Mitigates Cyclophosphamide‐Induced Oxidative Stress, Neuroinflammation, and Cognitive Dysfunction via Nrf2, NF‐κB, and Astrocytic GFAP Modulation in Wistar Albino Rats. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70514
Vancouver
Khan MA, Alam MM, Ali SM, Haque SE. Camphene Mitigates Cyclophosphamide‐Induced Oxidative Stress, Neuroinflammation, and Cognitive Dysfunction via Nrf2, NF‐κB, and Astrocytic GFAP Modulation in Wistar Albino Rats. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70514
BibTeX
@article{Khan2025,
author = {Khan, Mohd Almas and Alam, Mohammad Mumtaz and Ali, Syed Mansoor and Haque, Syed Ehtaishamul},
title = {Camphene Mitigates Cyclophosphamide‐Induced Oxidative Stress, Neuroinflammation, and Cognitive Dysfunction via Nrf2, NF‐κB, and Astrocytic GFAP Modulation in Wistar Albino Rats},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70514}
}
EUVIMED